In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, Bausch Health Companies Inc (NYSE: BHC) closed at $5.78 up 1.23% from its previous closing price of $5.71. In other words, the price has increased by $1.23 from its previous closing price. On the day, 1.35 million shares were traded. BHC stock price reached its highest trading level at $5.79 during the session, while it also had its lowest trading level at $5.645.
Ratios:
For a deeper understanding of Bausch Health Companies Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.23 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 2.02. For the most recent quarter (mrq), Quick Ratio is recorded 0.98 and its Current Ratio is at 1.31.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on August 02, 2024, Downgraded its rating to Underweight and sets its target price to $3 from $9 previously.
On July 10, 2024, Raymond James started tracking the stock assigning a Mkt Perform rating and target price of $8.
Jefferies Upgraded its Hold to Buy on September 20, 2023, whereas the target price for the stock was revised from $9 to $16.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 13 ’25 when Paulson John bought 3,564,059 shares for $5.94 per share. The transaction valued at 21,170,510 led to the insider holds 32,791,702 shares of the business.
Paulson John bought 1,005,376 shares of BHC for $5,499,407 on Jun 12 ’25. The Director now owns 29,227,643 shares after completing the transaction at $5.47 per share. On Jun 11 ’25, another insider, Paulson John, who serves as the Director of the company, bought 1,029,098 shares for $5.24 each. As a result, the insider paid 5,392,474 and bolstered with 28,222,267 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BHC now has a Market Capitalization of 2137386368 and an Enterprise Value of 23059388416. As of this moment, Bausch’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.07, and their Forward P/E ratio for the next fiscal year is 1.36. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.03. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.22. Its current Enterprise Value per Revenue stands at 2.339 whereas that against EBITDA is 7.415.
Stock Price History:
The Beta on a monthly basis for BHC is 0.46, which has changed by 0.072356224 over the last 52 weeks, in comparison to a change of 0.20799685 over the same period for the S&P500. Over the past 52 weeks, BHC has reached a high of $9.85, while it has fallen to a 52-week low of $4.25. The 50-Day Moving Average of the stock is -2.36%, while the 200-Day Moving Average is calculated to be -14.53%.
Shares Statistics:
For the past three months, BHC has traded an average of 1.99M shares per day and 1632790 over the past ten days. A total of 369.75M shares are outstanding, with a floating share count of 291.98M. Insiders hold about 21.04% of the company’s shares, while institutions hold 58.45% stake in the company. Shares short for BHC as of 1752537600 were 7436683 with a Short Ratio of 3.73, compared to 1749772800 on 8675986. Therefore, it implies a Short% of Shares Outstanding of 7436683 and a Short% of Float of 2.17.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0The stock’s 5-year Average Dividend Yield is 6.52.
